Literature DB >> 7790685

Vitamin C and the common cold: a retrospective analysis of Chalmers' review.

H Hemilä1, Z S Herman.   

Abstract

In 1975 Thomas Chalmers analyzed the possible effect of vitamin C on the common cold by calculating the average difference in the duration of cold episodes in vitamin C and control groups in seven placebo-controlled studies. He found that episodes were 0.11 +/- 0.24 (SE) days shorter in the vitamin C groups and concluded that there was no valid evidence to indicate that vitamin C is beneficial in the treatment of the common cold. Chalmers' review has been extensively cited in scientific articles and monographs. However, other reviewers have concluded that vitamin C significantly alleviates the symptoms of the common cold. A careful analysis of Chalmers' review reveals serious shortcomings. For example, Chalmers did not consider the amount of vitamin C used in the studies and included in his meta-analysis was a study in which only 0.025-0.05 g/day of vitamin C was administered to the test subjects. For some studies Chalmers used values that are inconsistent with the original published results. Using data from the same studies, we calculated that vitamin C (1-6 g/day) decreased the duration of the cold episodes by 0.93 +/- 0.22 (SE) days; the relative decrease in the episode duration was 21%. The current notion that vitamin C has no effect on the common cold seems to be based in large part on a faulty review written two decades ago.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790685     DOI: 10.1080/07315724.1995.10718483

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  17 in total

1.  Thomas Chalmers, vitamin C and the common cold.

Authors:  Harri Hemilä
Journal:  J R Soc Med       Date:  2016-02       Impact factor: 5.344

Review 2.  Treatment of the common cold.

Authors:  S B Mossad
Journal:  BMJ       Date:  1998-07-04

Review 3.  Problems and prospects of developing effective therapy for common cold viruses.

Authors:  S L Johnston
Journal:  Trends Microbiol       Date:  1997-02       Impact factor: 17.079

4.  Commentary: The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19.

Authors:  Harri Hemilä; Elizabeth Chalker
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

5.  Zinc lozenges may shorten the duration of colds: a systematic review.

Authors:  Harri Hemilä
Journal:  Open Respir Med J       Date:  2011-06-23

Review 6.  The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis.

Authors:  Harri Hemilä
Journal:  Allergy Asthma Clin Immunol       Date:  2014-11-27       Impact factor: 3.406

Review 7.  Vitamin C and Infections.

Authors:  Harri Hemilä
Journal:  Nutrients       Date:  2017-03-29       Impact factor: 5.717

8.  Duration of the common cold and similar continuous outcomes should be analyzed on the relative scale: a case study of two zinc lozenge trials.

Authors:  Harri Hemilä
Journal:  BMC Med Res Methodol       Date:  2017-05-12       Impact factor: 4.615

Review 9.  Vitamin C for preventing and treating the common cold.

Authors:  Harri Hemilä; Elizabeth Chalker
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

10.  Vitamin C supplementation slightly improves physical activity levels and reduces cold incidence in men with marginal vitamin C status: a randomized controlled trial.

Authors:  Carol S Johnston; Gillean M Barkyoumb; Sara S Schumacher
Journal:  Nutrients       Date:  2014-07-09       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.